23.06.2017 Study has proved that amino acid helps to defeat herpes
Scientists from the National Institutes of Health of the United States have found that glutamine supplements (one of the 20 standard amino acids involved in the protein) prevent the reactivation of herpes simplex virus (HSV). Currently, there are no remedies for HSV-1 and HSV-2 causing oral and genital herpes, UPI.com reports.
22.06.2017 A unique drug may change the treatment of influenza
Johnson & Johnson has carried out a second phase of testing of its experimental drug against the influenza virus. The studies have shown that the drug significantly reduced the viral exposure to people with influenza. The code name of the drug is Pimodivir. The major task is to help patients who are resistant to treatment by standard methods, as well as patients hospitalized with influenza
21.06.2017 "Smart bacteria" will take care of the rehabilitation in heart sufferers
Stanford University has designed a new technique that will be capable to restore the heart after a heart attack in the short term. According to BBC, scientists suggest to introduce bacteria that produce oxygen as a result of photosynthesis. Currently, the method was tested in rats. So, if a thrombus blocks a vessel, the heart experiences the oxygen starvation due to disturbed blood flow. But when a single-celled cyanobacterium Synechococcus elongatus capable of photosynthesis was implanted, it is possible to remove carbon dioxide and saturate the muscle cells in the heart with oxygen and sugar simultaneously.
20.06.2017 As it turned out, unusual bacteria are the source of powerful antibiotic
Scientists have discovered a natural antibiotic that can cope with resistant tuberculosis. According to News -medical.net, for example, in Russia by 2040, more than a third of all cases of tuberculosis will be sustainable. Therefore, a research for new drugs is necessary.
19.06.2017 Scientists on the verge of victory against Parkinson's disease
Scientists from the University of California have created a molecular compound for the control of Parkinson's disease - CLR01. It has been already tested on mice suffering from this neurodegenerative disease. CLR01 reduces the level of the toxic protein (alpha-synuclein) in the brain. This protein is associated with the development of Parkinson's disease, UPI.com reports.
16.06.2017 Scientists promise that daily insulin injections would have become a thing of the past
Millions of people in the world suffer from diabetes. According to New Atlas, diabetics have to constantly monitor blood sugar concentrations and do insulin injections. Glucagon-like peptide-1 (GLP-1) is usually used for type 2 diabetes. It makes the pancreas to release insulin, but this compound does not live long in the body.
15.06.2017 Scientists have discovered a gene that helps to live to 100 years
Japanese scientists have analyzed the data of 4312 volunteers under 80 years and 530 people aged 95 and over (most people in this group were more than 100 years old). The experts have established that CLEC3B gene in long-livers had certain characteristics. CLEC3B gene encodes tetranectin protein that prevents the spread of cancer and promotes the formation of bone tissue, The Daily Mail reports.
22.03.2018 Scientists have found a "switch" responsible for a tumor growth
Scientists from the Karolinsky Institute have carried out a study in mice. They have revealed a "genetic switch" that regulates the growth of cancer cells. When it’s "off" the development of cancer in rodents was prevented. Normal cells were not damaged, as their growth is controlled by another "switch", The Hindustan Times reports.
23.03.2018 A remedy for nausea and vomiting can help people suffering from sleep apnea
Dronabinol is a cannabinoid agonist prescribed rarely for nausea and vomiting to patients undergoing chemotherapy. A new study conducted at the University of Illinois, has found that dronabinol fights against sleep apnea successfully. Sleep apnea is a disorder that increases the risk of coronary heart disease, stroke, hypertension and type 2 diabetes.
12.06.2017 Scientists have proven the effectiveness of a new remedy for psoriasis
Experts have summed the results of Phase III of two clinical trials of the medicinal product tildrakizumab - antibody having a specific purpose. The medicinal product belongs to a class of biological agents that make the body to fight against a disease. The experts consider the results are promising, UPI.com reports.